Therapeuticsmd Inc (TXMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 95 | -569 | 50 | -102 | -653 |
| Depreciation Amortization | 325 | 1,193 | 287 | 191 | 249 |
| Accounts payable and accrued liabilities | -340 | 119 | 5 | 92 | -82 |
| Other Working Capital | -367 | 1,663 | 1,103 | 498 | 473 |
| Other Operating Activity | 1,231 | 48 | 634 | 401 | 712 |
| Operating Cash Flow | $944 | $2,454 | $2,079 | $1,080 | $699 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Financing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Beginning Cash Position | 7,483 | 5,059 | 5,059 | 5,059 | 5,059 |
| End Cash Position | 8,419 | 7,483 | 7,115 | 6,069 | 5,745 |
| Net Cash Flow | $936 | $2,424 | $2,056 | $1,010 | $686 |
| Free Cash Flow | |||||
| Operating Cash Flow | 944 | 2,454 | 2,079 | 1,080 | 699 |
| Free Cash Flow | 944 | 2,454 | 2,079 | 1,080 | 699 |